risperidone has been researched along with Fever in 16 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Fever: An abnormal elevation of body temperature, usually as a result of a pathologic process.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clozapine is the gold-standard antipsychotic medication for treatment-refractory schizophrenia (TRS)." | 7.83 | Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone? ( Cherry, S; Halangoda, P; Siskind, D; Spivak, V; Wysoczanski, D, 2016) |
| "We report a case of neuroleptic malignant syndrome in a woman who assumed risperidone for schizoaffective disorders." | 7.75 | A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman. ( De Sarro, G; Ferraro, M; Gallelli, L; Palleria, C; Spagnuolo, V, 2009) |
| "A 39-year-old man with schizophrenia developed severe catatonia, hyperthermia, muscle rigidity, tachycardia, leukocytosis, and elevated muscle enzyme levels while receiving zotepine therapy." | 7.73 | Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome. ( Chen, CC; Tsai, JH; Yang, MJ; Yang, P; Yen, JY, 2005) |
| "To report and discuss a case of neuroleptic malignant syndrome (NMS) with delayed onset of fever in a patient taking risperidone." | 7.73 | Neuroleptic malignant syndrome with delayed onset of fever following risperidone administration. ( Angeles, V; Eisenstein, R; Norris, B; Seale, JP, 2006) |
| "We present a patient with juvenile neuronal ceroid lipofuscinosis who developed a neuroleptic malignant syndrome when treated for hallucinations with a very low dose of risperidone, an atypical neuroleptic medication with usually few extrapyramidal side-effects." | 7.72 | Neuroleptic malignant syndrome in juvenile neuronal ceroid lipofuscinosis associated with low-dose risperidone therapy. ( Buyse, GM; Proost, JE; Van Hove, JL; Vercammen, L, 2003) |
| " Three nursing-home residents who suffered from multiple somatic disorders and dementia, two men aged 78 and 76 years respectively and a woman aged 72 years, developed neuroleptic malignant syndrome following the use of risperidone." | 7.72 | [Neuroleptic malignant syndrome in users of risperidone]. ( de Jonghe-Rouleau, AP; Gerritsen, AA; Stienstra-Liem, LH, 2004) |
| "Pretreatment with risperidone (0." | 5.32 | Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome. ( Kato, S; Nisijima, K; Shioda, K; Takano, K; Yoshino, T, 2004) |
| "Clozapine is the gold-standard antipsychotic medication for treatment-refractory schizophrenia (TRS)." | 3.83 | Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone? ( Cherry, S; Halangoda, P; Siskind, D; Spivak, V; Wysoczanski, D, 2016) |
| "We report a case of neuroleptic malignant syndrome in a woman who assumed risperidone for schizoaffective disorders." | 3.75 | A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman. ( De Sarro, G; Ferraro, M; Gallelli, L; Palleria, C; Spagnuolo, V, 2009) |
| "A 39-year-old man with schizophrenia developed severe catatonia, hyperthermia, muscle rigidity, tachycardia, leukocytosis, and elevated muscle enzyme levels while receiving zotepine therapy." | 3.73 | Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome. ( Chen, CC; Tsai, JH; Yang, MJ; Yang, P; Yen, JY, 2005) |
| "To report and discuss a case of neuroleptic malignant syndrome (NMS) with delayed onset of fever in a patient taking risperidone." | 3.73 | Neuroleptic malignant syndrome with delayed onset of fever following risperidone administration. ( Angeles, V; Eisenstein, R; Norris, B; Seale, JP, 2006) |
| "We present a patient with juvenile neuronal ceroid lipofuscinosis who developed a neuroleptic malignant syndrome when treated for hallucinations with a very low dose of risperidone, an atypical neuroleptic medication with usually few extrapyramidal side-effects." | 3.72 | Neuroleptic malignant syndrome in juvenile neuronal ceroid lipofuscinosis associated with low-dose risperidone therapy. ( Buyse, GM; Proost, JE; Van Hove, JL; Vercammen, L, 2003) |
| " Three nursing-home residents who suffered from multiple somatic disorders and dementia, two men aged 78 and 76 years respectively and a woman aged 72 years, developed neuroleptic malignant syndrome following the use of risperidone." | 3.72 | [Neuroleptic malignant syndrome in users of risperidone]. ( de Jonghe-Rouleau, AP; Gerritsen, AA; Stienstra-Liem, LH, 2004) |
| " The patient had long-standing schizophrenia and had been taking risperidone for 2 years, without evidence of abnormal movements." | 3.71 | Hyperthermia and chronic pancerebellar syndrome after cocaine abuse. ( Dissin, J; Selcer, UM; Tanvetyanon, T, 2001) |
| "Risperidone pretreatment significantly attenuated increases in the levels of DA, 5-HT, glutamate, and NOx." | 1.36 | Effect of risperidone on acute methamphetamine-induced hyperthermia in rats. ( Kato, S; Nisijima, K; Shioda, K; Yoshino, T, 2010) |
| " The diagnosis of rhabdomyolysis was confirmed by myoglobinemia dosage and ortholuidine test." | 1.32 | [Rhabdomyolysis associated with respiratory infection in chronic psychiatric patients during neuroleptic treatment]. ( Busiello, L; Cascella, M; De Robertis, E; Di Domenico, MG; Palmese, S; Pezza, M, 2003) |
| "Pretreatment with risperidone (0." | 1.32 | Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome. ( Kato, S; Nisijima, K; Shioda, K; Takano, K; Yoshino, T, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 11 (68.75) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blessing, WW | 1 |
| Blessing, EM | 1 |
| Mohammed, M | 1 |
| Ootsuka, Y | 1 |
| Cherry, S | 1 |
| Siskind, D | 1 |
| Spivak, V | 1 |
| Wysoczanski, D | 1 |
| Halangoda, P | 1 |
| Shioda, K | 3 |
| Nisijima, K | 3 |
| Yoshino, T | 3 |
| Kuboshima, K | 1 |
| Iwamura, T | 1 |
| Yui, K | 1 |
| Kato, S | 3 |
| Gallelli, L | 1 |
| Spagnuolo, V | 1 |
| Palleria, C | 1 |
| De Sarro, G | 1 |
| Ferraro, M | 1 |
| Pezza, M | 1 |
| Busiello, L | 1 |
| Palmese, S | 1 |
| Cascella, M | 1 |
| Di Domenico, MG | 1 |
| De Robertis, E | 1 |
| Vercammen, L | 1 |
| Buyse, GM | 1 |
| Proost, JE | 1 |
| Van Hove, JL | 1 |
| Takano, K | 1 |
| Gerritsen, AA | 1 |
| de Jonghe-Rouleau, AP | 1 |
| Stienstra-Liem, LH | 1 |
| Tsai, JH | 1 |
| Yang, P | 1 |
| Yen, JY | 1 |
| Chen, CC | 1 |
| Yang, MJ | 1 |
| Cawrse, N | 1 |
| Wilson, S | 1 |
| Williams, M | 1 |
| Burge, T | 1 |
| Norris, B | 1 |
| Angeles, V | 1 |
| Eisenstein, R | 1 |
| Seale, JP | 1 |
| Swanson, CL | 1 |
| Price, WA | 1 |
| McEvoy, JP | 1 |
| Simpson, GM | 1 |
| Oerther, S | 1 |
| Ahlenius, S | 1 |
| Tanvetyanon, T | 1 |
| Dissin, J | 1 |
| Selcer, UM | 1 |
16 other studies available for risperidone and Fever
| Article | Year |
|---|---|
Clozapine, chlorpromazine and risperidone dose-dependently reduce emotional hyperthermia, a biological marker of salience.
Topics: Animals; Arousal; Chlorpromazine; Clozapine; Dose-Response Relationship, Drug; Emotions; Fever; Male | 2017 |
Fever, confusion, acute kidney injury: is this atypical neuroleptic malignant syndrome following polypharmacy with clozapine and risperidone?
Topics: Acute Kidney Injury; Aged; Antipsychotic Agents; Clozapine; Confusion; Fever; Humans; Male; Neurolep | 2016 |
Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
Topics: Analysis of Variance; Animals; Body Temperature; Disease Models, Animal; Dopamine; Dopamine Antagoni | 2008 |
A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman.
Topics: Antipsychotic Agents; Female; Fever; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Psychotic | 2009 |
Effect of risperidone on acute methamphetamine-induced hyperthermia in rats.
Topics: Acute Disease; Animals; Chronic Disease; Fever; Male; Methamphetamine; Rats; Rats, Wistar; Risperido | 2010 |
[Rhabdomyolysis associated with respiratory infection in chronic psychiatric patients during neuroleptic treatment].
Topics: Acute Kidney Injury; Adult; Antipsychotic Agents; Benzodiazepines; Diagnosis, Differential; Fever; H | 2003 |
Neuroleptic malignant syndrome in juvenile neuronal ceroid lipofuscinosis associated with low-dose risperidone therapy.
Topics: Adult; Antipsychotic Agents; Creatine Kinase; Dopamine; Female; Fever; Hallucinations; Humans; Intel | 2003 |
Memantine, an NMDA antagonist, prevents the development of hyperthermia in an animal model for serotonin syndrome.
Topics: 5-Hydroxytryptophan; Animals; Body Temperature; Clorgyline; Disease Models, Animal; Dizocilpine Male | 2004 |
[Neuroleptic malignant syndrome in users of risperidone].
Topics: Aged; Antipsychotic Agents; Dementia; Fatal Outcome; Female; Fever; Humans; Male; Neuroleptic Malign | 2004 |
Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome.
Topics: Antipsychotic Agents; Blood Chemical Analysis; Catatonia; Dibenzothiepins; Disease Progression; Feve | 2005 |
Neuroleptic malignant syndrome in the burns patient?
Topics: Antipsychotic Agents; Burns; Depressive Disorder; Fatal Outcome; Female; Fever; Humans; Middle Aged; | 2006 |
Neuroleptic malignant syndrome with delayed onset of fever following risperidone administration.
Topics: Female; Fever; Humans; Middle Aged; Neuroleptic Malignant Syndrome; Risperidone; Time Factors | 2006 |
Effects of concomitant risperidone and lithium treatment.
Topics: Antipsychotic Agents; Confusion; Creatine Kinase; Drug Therapy, Combination; Fever; Humans; Isoxazol | 1995 |
EPS with fever versus NMS.
Topics: Basal Ganglia Diseases; Cholinergic Antagonists; Diagnosis, Differential; Dopamine Agonists; Female; | 1996 |
Atypical antipsychotics and dopamine D(1) receptor agonism: an in vivo experimental study using core temperature measurements in the rat.
Topics: Animals; Antipsychotic Agents; Benzazepines; Benzodiazepines; Clozapine; Dibenzothiazepines; Dopamin | 2000 |
Hyperthermia and chronic pancerebellar syndrome after cocaine abuse.
Topics: Adult; Antipsychotic Agents; Cerebellar Diseases; Chronic Disease; Cocaine-Related Disorders; Diagno | 2001 |